Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-12-30 13:14:58
Reporting Period:
Accepted Time:
2020-12-30 13:14:58
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1755237 Cyclerion Therapeutics Inc. CYCN () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478244 G Mark Currie C/o Cyclerion Therapeutics, Inc.
301 Binney Street
Cambridge MA 02142
President And Cso No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-28 20,107 $3.01 251,648 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. The proceeds from the sale are intended to cover income taxes arising out of prior stock option exercises, including those in which the reporting person held the underlying shares.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.94 to $3.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.